• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体因子 I 缺陷:并非如此罕见的免疫缺陷:新突变和首个大片段缺失的特征。

Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion.

机构信息

Unidad de Inmunología Hospital Universitario La Paz and Hospital La Paz Health Research Institute (IdiPAZ), Madrid, Spain.

出版信息

Orphanet J Rare Dis. 2012 Jun 18;7:42. doi: 10.1186/1750-1172-7-42.

DOI:10.1186/1750-1172-7-42
PMID:22710145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3458969/
Abstract

BACKGROUND

Complement Factor I (CFI) is a serine protease with an important role in complement alternative pathway regulation. Complete factor I deficiency is strongly associated with severe infections. Approximately 30 families with this deficiency have been described worldwide.

PATIENTS AND METHODS

We have studied five new Spanish families suffering from CFI deficiency. From 19 screened people, 7 homozygous, 10 heterozygous and 2 healthy subjects were identified. Clinical, biochemical and genetic descriptions are included.

RESULTS

Molecular studies demonstrated 4 novel mutations in the screened individuals; amongst them, we describe here the first great gene deletion reported in the CFI locus, which includes full exon 2 and part of the large intron 1.

CONCLUSION

CFI deficiency is possibly an underestimated defect and the eventual existence of this deficiency should be tested in those patients exhibiting low C3 and recurrent bacterial infections. We propose a simple diagnostic flowchart to help clinicians in the identification and correct diagnosis of such patients.

摘要

背景

补体因子 I(CFI)是一种丝氨酸蛋白酶,在补体替代途径的调节中具有重要作用。完全缺乏因子 I 与严重感染密切相关。全世界已经描述了大约 30 个具有这种缺陷的家族。

患者和方法

我们研究了五个来自西班牙的患有 CFI 缺陷的新家族。在筛选出的 19 人中,发现 7 名纯合子、10 名杂合子和 2 名健康个体。包括临床、生化和遗传描述。

结果

分子研究在筛选出的个体中发现了 4 个新的突变;其中,我们在这里描述了 CFI 基因座中首次报道的大基因缺失,该缺失包括完整的外显子 2 和部分大内含子 1。

结论

CFI 缺陷可能是一个被低估的缺陷,最终应该在那些表现出低 C3 和反复细菌感染的患者中检测到这种缺陷的存在。我们提出了一个简单的诊断流程图,以帮助临床医生识别和正确诊断这些患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/be7ddf448bd5/1750-1172-7-42-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/dd44298e9de7/1750-1172-7-42-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/f17d21fc6129/1750-1172-7-42-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/ac49bdad7302/1750-1172-7-42-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/be7ddf448bd5/1750-1172-7-42-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/dd44298e9de7/1750-1172-7-42-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/f17d21fc6129/1750-1172-7-42-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/ac49bdad7302/1750-1172-7-42-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1c/3458969/be7ddf448bd5/1750-1172-7-42-4.jpg

相似文献

1
Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion.补体因子 I 缺陷:并非如此罕见的免疫缺陷:新突变和首个大片段缺失的特征。
Orphanet J Rare Dis. 2012 Jun 18;7:42. doi: 10.1186/1750-1172-7-42.
2
Novel CFI mutation in a patient with leukocytoclastic vasculitis may redefine the clinical spectrum of Complement Factor I deficiency.白细胞破碎性血管炎患者中的新型补体因子I(CFI)突变可能会重新定义补体因子I缺乏症的临床谱。
Clin Immunol. 2015 Oct;160(2):315-8. doi: 10.1016/j.clim.2015.05.004. Epub 2015 May 16.
3
Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations.早期与晚期诊断补体因子 I 缺乏症:两个具有新型纯合 CFI 突变的家系中临床后果的说明。
J Clin Immunol. 2017 Nov;37(8):781-789. doi: 10.1007/s10875-017-0447-x. Epub 2017 Sep 23.
4
Clinical laboratory standard capillary protein electrophoresis alerted of a low C3 state and lead to the identification of a Factor I deficiency due to a novel homozygous mutation.临床实验室标准毛细管蛋白电泳提示C3水平较低,并因一种新的纯合突变导致了I因子缺乏的诊断。
Immunol Lett. 2016 Jun;174:19-22. doi: 10.1016/j.imlet.2016.04.011. Epub 2016 Apr 14.
5
Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.补体因子 I 缺乏导致的皮肤血管炎和反复感染。
Front Immunol. 2018 Apr 11;9:735. doi: 10.3389/fimmu.2018.00735. eCollection 2018.
6
The first confirmed case with C3 deficiency caused by compound heterozygous mutations in the C3 gene; a new aspect of pathogenesis for C3 deficiency.首例由C3基因复合杂合突变导致C3缺乏的确诊病例;C3缺乏发病机制的新方面。
Blood Cells Mol Dis. 2008 May-Jun;40(3):410-3. doi: 10.1016/j.bcmd.2007.11.002. Epub 2008 Jan 16.
7
Molecular characterization of Complement Factor I deficiency in two Spanish families.
Mol Immunol. 2008 May;45(10):2764-71. doi: 10.1016/j.molimm.2008.02.008. Epub 2008 Mar 28.
8
Complement factor I deficiency in a family with recurrent infections.
Immunopharmacology. 1997 Dec;38(1-2):207-13. doi: 10.1016/s0162-3109(97)00080-5.
9
Molecular characterization of two novel cases of complete complement inhibitor Factor I deficiency.两种新型完全补体抑制剂因子 I 缺乏症的分子特征。
Mol Immunol. 2011 Apr;48(8):1068-72. doi: 10.1016/j.molimm.2011.01.012. Epub 2011 Feb 12.
10
Molecular basis of complement factor I deficiency in Tunisian atypical haemolytic and uraemic syndrome patients.突尼斯非典型溶血尿毒症综合征患者补体因子I缺乏的分子基础
Nephrology (Carlton). 2019 Mar;24(3):357-364. doi: 10.1111/nep.13217.

引用本文的文献

1
Complete Complement Factor I (CFI) deficiency: a systematic review of forty-nine patients including three novel cases.完全补体因子I(CFI)缺乏症:对49例患者的系统评价,包括3例新病例。
BMC Immunol. 2025 Jul 26;26(1):54. doi: 10.1186/s12865-025-00739-y.
2
The Complement System.补体系统
Adv Exp Med Biol. 2025;1476:147-198. doi: 10.1007/978-3-031-85340-1_7.
3
Pediatric Immunodeficiency Caused by Complement Classical and Alternative Pathway Defects Due to a Homozygous CFI Variant: A Case Report.因纯合子CFI变异导致补体经典途径和替代途径缺陷引起的小儿免疫缺陷:一例报告

本文引用的文献

1
Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?自身抗体因子 I 在非典型溶血性尿毒症综合征患者中的作用:与疾病相关还是一种伴随现象?
Clin J Am Soc Nephrol. 2012 Mar;7(3):417-26. doi: 10.2215/CJN.05750611. Epub 2012 Jan 5.
2
Atypical hemolytic uremic syndrome.非典型溶血尿毒综合征。
Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60.
3
Structural basis for complement factor I control and its disease-associated sequence polymorphisms.补体因子 I 调控及其与疾病相关序列多态性的结构基础。
Cureus. 2025 Apr 7;17(4):e81827. doi: 10.7759/cureus.81827. eCollection 2025 Apr.
4
The specific contributions of factor H and factor I in controlling fluid phase activation of the alternative complement pathway.补体替代途径中H因子和I因子在控制液相激活方面的具体作用。
Sci Rep. 2025 Mar 29;15(1):10883. doi: 10.1038/s41598-025-95533-6.
5
The role of complement factor I rare genetic variants in age related macular degeneration in Finland.补体因子I罕见基因变异在芬兰年龄相关性黄斑变性中的作用。
Hum Mol Genet. 2025 Feb 1;34(3):218-228. doi: 10.1093/hmg/ddae165.
6
Case Report: Hypocomplementemic urticarial vasculitis syndrome in a pediatric patient with complement factor 1 deficiency.病例报告:一名患有补体因子1缺乏症的儿科患者的低补体血症性荨麻疹性血管炎综合征
Front Pediatr. 2024 Sep 23;12:1448094. doi: 10.3389/fped.2024.1448094. eCollection 2024.
7
Functional evaluation of rare variants in complement factor I using a minigene assay.利用微基因检测方法对补体因子 I 中的稀有变异进行功能评估。
Front Immunol. 2024 Aug 22;15:1446081. doi: 10.3389/fimmu.2024.1446081. eCollection 2024.
8
Complement or insult: the emerging link between complement cascade deficiencies and pathology of myeloid malignancies.补体系统缺陷与髓系恶性肿瘤发病机制之间新的关联:补充还是损伤?
J Leukoc Biol. 2024 Nov 4;116(5):966-984. doi: 10.1093/jleuko/qiae130.
9
Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.蛋白质组学鉴定出酒精相关性肝炎患者的补体蛋白特征。
JCI Insight. 2024 Apr 4;9(9):e174127. doi: 10.1172/jci.insight.174127.
10
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.补体系统凝集素途径的激活、调控、疾病关联及与其他(蛋白水解)系统的相互作用。
Int J Mol Sci. 2024 Jan 26;25(3):1566. doi: 10.3390/ijms25031566.
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12839-44. doi: 10.1073/pnas.1102167108. Epub 2011 Jul 18.
4
Disease-causing mutations in genes of the complement system.补体系统基因中的致病突变。
Am J Hum Genet. 2011 Jun 10;88(6):689-705. doi: 10.1016/j.ajhg.2011.05.011.
5
Complement factor I in health and disease.补体因子 I 在健康与疾病中的作用。
Mol Immunol. 2011 Aug;48(14):1611-20. doi: 10.1016/j.molimm.2011.04.004. Epub 2011 Apr 29.
6
Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.对非典型溶血尿毒综合征病因学的认识进展。
Br J Haematol. 2010 Sep;150(5):529-42. doi: 10.1111/j.1365-2141.2010.08295.x. Epub 2010 Jul 14.
7
Primary immunodeficiencies: 2009 update.原发性免疫缺陷病:2009 年更新。
J Allergy Clin Immunol. 2009 Dec;124(6):1161-78. doi: 10.1016/j.jaci.2009.10.013.
8
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.在非典型溶血性尿毒症综合征患者中,补体因子 H 自身抗体与 CFHR1、CFHR3、CFHR4 的缺失以及 CFH、CFI、CD46 和 C3 中的突变相关。
Blood. 2010 Jan 14;115(2):379-87. doi: 10.1182/blood-2009-05-221549. Epub 2009 Oct 27.
9
Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.血浆中补体因子H相关(CFHR)蛋白的特征分析揭示了与非典型溶血尿毒综合征相关的CFHR1新基因变异。
Blood. 2009 Nov 5;114(19):4261-71. doi: 10.1182/blood-2009-05-223834. Epub 2009 Sep 10.
10
Complement regulators and inhibitory proteins.补体调节蛋白和抑制蛋白。
Nat Rev Immunol. 2009 Oct;9(10):729-40. doi: 10.1038/nri2620. Epub 2009 Sep 4.